A Phase I, Single Center, Randomized, Double-Blind, Placebo-Controlled Single Ascending Oral Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7268 in Healthy Japanese Subjects.

Trial Profile

A Phase I, Single Center, Randomized, Double-Blind, Placebo-Controlled Single Ascending Oral Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7268 in Healthy Japanese Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Jan 2013

At a glance

  • Drugs AZD 7268 (Primary)
  • Indications Anxiety disorders; Depression
  • Focus Adverse reactions
  • Acronyms JSAD
  • Most Recent Events

    • 11 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Oct 2009 Planned end date changed from 1 Aug 2009 to 1 Oct 2009 as reported by ClinicalTrials.gov.
    • 06 Oct 2009 Planned number of patients changed from 40 to 56 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top